Histone deacetylases and cancer

被引：391

作者：

Barneda-Zahonero, Bruna ^{[1
]}

Parra, Maribel ^{[1
]}

机构：

[1] Bellvitge Biomed Res Inst IDIBELL, Cellular Differentiat Grp, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Spain

来源：

MOLECULAR ONCOLOGY | 2012年 / 6卷 / 06期

关键词：

Protein acetylation; Histone deacetylases; Cancer; HUMAN BREAST-CANCER; CLASS-II; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; PRECLINICAL ACTIVITY; CELL-PROLIFERATION; DOWN-REGULATION; HDAC INHIBITOR; POOR-PROGNOSIS;

D O I：

10.1016/j.molonc.2012.07.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Reversible acetylation of histone and non-histone proteins is one of the most abundant post-translational modifications in eukaryotic cells. Protein acetylation and deacetylation are achieved by the antagonistic actions of two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). Aberrant protein acetylation, particularly on histones, has been related to cancer while abnormal expression of HDACs has been found in a broad range of cancer types. Therefore, HDACs have emerged as promising targets in cancer therapeutics, and the development of HDAC inhibitors (HDIs), a rapidly evolving area of clinical research. However, the contributions of specific HDACs to a given cancer type remain incompletely understood. The aim of this review is to summarize the current knowledge concerning the role of HDACs in cancer with special emphasis on what we have learned from the analysis of patient samples. (c) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：579 / 589

页数：11

共 118 条

[91] The consensus coding sequences of human breast and colorectal cancers [J].

Sjoeblom, Tobias ;

Jones, Sian ;

Wood, Laura D. ;

Parsons, D. Williams ;

Lin, Jimmy ;

Barber, Thomas D. ;

Mandelker, Diana ;

Leary, Rebecca J. ;

Ptak, Janine ;

Silliman, Natalie ;

Szabo, Steve ;

Buckhaults, Phillip ;

Farrell, Christopher ;

Meeh, Paul ;

Markowitz, Sanford D. ;

Willis, Joseph ;

Dawson, Dawn ;

Willson, James K. V. ;

Gazdar, Adi F. ;

Hartigan, James ;

Wu, Leo ;

Liu, Changsheng ;

Parmigiani, Giovanni ;

Park, Ben Ho ;

Bachman, Kurtis E. ;

Papadopoulos, Nickolas ;

Vogelstein, Bert ;

Kinzler, Kenneth W. ;

Velculescu, Victor E. .

SCIENCE, 2006, 314 (5797) :268-274

[92] Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms [J].

Skov, Vibe ;

Larsen, Thomas Stauffer ;

Thomassen, Mads ;

Riley, Caroline Hasselbalch ;

Jensen, Morten K. ;

Bjerrum, Ole Weis ;

Kruse, Torben A. ;

Hasselbalch, Hans Carl .

LEUKEMIA & LYMPHOMA, 2012, 53 (01) :123-129

[93] Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells [J].

Song, B. ;

Wang, Y. ;

Xi, Y. ;

Kudo, K. ;

Bruheim, S. ;

Botchkina, G. I. ;

Gavin, E. ;

Wan, Y. ;

Formentini, A. ;

Kornmann, M. ;

Fodstad, O. ;

Ju, J. .

ONCOGENE, 2009, 28 (46) :4065-4074

[94] Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays [J].

Stark, Mitchell ;

Hayward, Nicholas .

CANCER RESEARCH, 2007, 67 (06) :2632-2642

[95] The language of covalent histone modifications [J].

Strahl, BD ;

Allis, CD .

NATURE, 2000, 403 (6765) :41-45

[96] HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer [J].

Stronach, Euan A. ;

Alfraidi, Albandri ;

Rama, Nona ;

Datler, Christoph ;

Studd, James B. ;

Agarwal, Roshan ;

Guney, Tankut G. ;

Gourley, Charlie ;

Hennessy, Bryan T. ;

Mills, Gordon B. ;

Mai, Antonello ;

Brown, Robert ;

Dina, Roberto ;

Gabra, Hani .

CANCER RESEARCH, 2011, 71 (13) :4412-4422

[97]

Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087

[98] Histone Deacetylase Inhibitors Demonstrate Significant Preclinical Activity as Single Agents, and in Combination with Bortezomib in Waldenstrom's Macroglobulinemia [J].

Sun, Jenny Y. ;

Xu, Lian ;

Tseng, Hsuyi ;

Ciccarelli, Bryan ;

Fulciniti, Mariateresa ;

Hunter, Zachary R. ;

Maghsoudi, Kaveh ;

Hatjiharissi, Evdoxia ;

Zhou, Yangsheng ;

Yang, Guang ;

Zhu, Biao ;

Liu, Xia ;

Gong, P. ;

Ioakimidis, Leukothea ;

Sheehy, Patricia ;

Patterson, Christopher J. ;

Munshi, Nikhil C. ;

O'Connor, Owen A. ;

Treon, Steven P. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (01) :152-156

[99] HDAC4 Represses Vascular Endothelial Growth Factor Expression in Chondrosarcoma by Modulating RUNX2 Activity [J].

Sun, Xiaojuan ;

Wei, Lei ;

Chen, Qian ;

Terek, Richard M. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (33) :21881-21890

[100] Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor [J].

Vannini, A ;

Volpari, C ;

Filocamo, G ;

Casavola, EC ;

Brunetti, M ;

Renzoni, D ;

Chakravarty, P ;

Paolini, C ;

De Francesco, R ;

Gallinari, P ;

Steinkühler, C ;

Di Marco, S .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (42) :15064-15069

← 3 4 5 6 7 8 9 10 11 12 →